Hot competition in commercialization of the first new drug in Korea.

Since the second half of 1980s the research oriented pharmaceutical companies have made quite an investment for an R&D of new drug discovery, and now is the time for these companies to visualize their fruit for the first time in history of Korea.

The candidate items included Mirican inj. (DW166HC) of Dong-Wha (a radiological drug for a liver cancer), EGF (DWP401) of Daewoong (Gene recombinan...